PCOS Hormone Panel
A targeted nine-marker hormonal and metabolic screen designed to assess the key features of polycystic ovary syndrome — including androgens.
Erectile dysfunction is frequently caused by measurable hormonal, metabolic, or cardiovascular imbalances — blood testing identifies the underlying driver so treatment can be targeted effectively rather than guessed at.
Erectile dysfunction (ED) — defined as the consistent or recurrent inability to achieve or maintain an erection sufficient for satisfactory sexual intercourse — affects an estimated one in five men in the UK at any given time. While psychological factors are frequently cited as a cause, research consistently shows that the majority of men with persistent ED have a measurable physical driver — and in many cases, a correctable one identifiable through targeted blood testing.
Testosterone is the primary androgen governing male sexual function. Low testosterone — assessed via total testosterone and SHBG — reduces both libido and the vascular response required for erection. Crucially, total testosterone can appear normal while free (biologically active) testosterone is low if SHBG is elevated, which is why both markers must be assessed together. LH and FSH from the pituitary distinguish testicular failure from hypothalamic suppression — an important distinction for determining the most appropriate treatment pathway.
Metabolic health is equally central. Type 2 diabetes and insulin resistance — assessed via HbA1c — cause erectile dysfunction through two distinct mechanisms: endothelial dysfunction impairing penile arterial vasodilation, and autonomic neuropathy disrupting the nerve signals required for erection. Hypothyroidism reduces testosterone production and impairs vascular reactivity. Elevated CRP and systemic inflammation predict cardiovascular endothelial function — and ED is increasingly recognised as an early marker of cardiovascular risk. A comprehensive male hormone and metabolic panel addresses all of these dimensions simultaneously.
Physical and psychological causes of erectile dysfunction commonly co-exist and reinforce each other — performance anxiety exacerbates hormonally driven ED, while chronic ED caused by low testosterone or metabolic dysfunction inevitably generates psychological distress. Blood tests identify the treatable physical contributors — including hormonal, metabolic, and inflammatory factors — that psychological therapy alone cannot address. Treating the physical cause frequently resolves the psychological component simultaneously.
Erectile dysfunction caused by hormonal or metabolic imbalance is typically accompanied by other systemic symptoms that reinforce the underlying diagnosis.
Erectile dysfunction results from disruption of the hormonal signals, vascular function, or neurological pathways required for normal erectile physiology.
A comprehensive male hormone and metabolic panel addresses the key physiological drivers of erectile dysfunction in a single blood draw.
These conditions are among the most common identifiable physical causes of erectile dysfunction in UK men.
A structured investigation of erectile dysfunction prioritises the hormonal and metabolic markers most likely to identify a correctable cause.
Total testosterone, SHBG, LH, and FSH form the core hormonal evaluation. SHBG is critical — high SHBG reduces biologically active testosterone and is common in older men and those with liver or thyroid dysfunction. LH and FSH distinguish testicular from pituitary causes, directing the most appropriate treatment.
Oestradiol and DHEA-S assess hormonal balance beyond testosterone alone. Elevated oestradiol from aromatisation in adipose tissue suppresses the pituitary-gonadal axis and reduces libido independently of testosterone levels — addressing this is a key component of a complete male hormone assessment.
HbA1c and fasting glucose identify insulin resistance and type 2 diabetes — the leading metabolic causes of endothelial dysfunction and vascular ED. Early identification allows lifestyle and pharmacological intervention that may prevent progressive vascular damage.
TSH and CRP complete the assessment. Thyroid dysfunction and systemic inflammation independently impair testosterone metabolism and penile vascular reactivity — both are easily treated once identified and are important components of a comprehensive ED blood panel.
Private blood tests analysed by UK-accredited laboratories.
A targeted nine-marker hormonal and metabolic screen designed to assess the key features of polycystic ovary syndrome — including androgens.
A five-marker adrenal and stress hormone panel measuring cortisol, DHEAS, DHEA, aldosterone, and ACTH — designed for those investigating HPA axis function.
A six-marker hormone panel measuring FSH, LH, oestradiol, progesterone, testosterone, and AMH.
A focused panel measuring testosterone, SHBG, oestradiol, prolactin, thyroid function, HbA1c, and fasting glucose.
A 20-marker comprehensive hormone and wellbeing panel covering sex hormones, adrenal markers, thyroid function, metabolic indicators.
A 28-biomarker advanced panel covering full blood count, thyroid (TSH, FT4), extended liver and kidney function, full cholesterol, HbA1c, iron status, and CRP.
Evidence-based lifestyle modifications improve endothelial function, testosterone levels, and erectile performance — and are most effective when guided by blood test results.
While erectile dysfunction is rarely dangerous in itself, certain accompanying symptoms require urgent medical assessment.
These can point to a more serious underlying cause and should not be ignored.
Yes — low testosterone is one of the most common physical causes of erectile dysfunction, particularly in men over 35. Testosterone drives both sexual desire and the vascular response required for erection. However, total testosterone alone can be misleading — SHBG (sex hormone-binding globulin) determines how much testosterone is biologically active, and elevated SHBG can create functional deficiency even when total testosterone appears normal. Both markers should be assessed together.
Type 2 diabetes is one of the leading physical causes of erectile dysfunction. Chronically elevated blood glucose — reflected by HbA1c — damages the endothelial cells lining penile blood vessels and impairs the autonomic nerves required to initiate erection. ED affects an estimated 50% of men with diabetes within ten years of diagnosis. Early identification of insulin resistance through blood testing allows lifestyle intervention before irreversible vascular damage occurs.
A comprehensive ED blood panel should include: total testosterone, SHBG, LH, FSH, oestradiol, DHEA-S, TSH, HbA1c, and CRP. Together these markers cover the hormonal, metabolic, thyroid, and inflammatory dimensions of erectile function — identifying the specific driver so treatment can be precisely targeted.
Yes — both hypothyroidism and hyperthyroidism are associated with erectile dysfunction. Hypothyroidism reduces testosterone production and impairs penile vascular smooth muscle relaxation. It is among the most commonly overlooked causes of ED and is easily identified and treated. A TSH blood test should be included in any comprehensive male sexual health assessment.
ED is increasingly recognised as an early marker of generalised cardiovascular disease. The penile arteries are smaller than the coronary arteries and become symptomatic from atherosclerosis earlier — meaning ED can precede symptomatic heart disease by three to five years. Elevated CRP, high HbA1c, and lipid abnormalities identified on a blood panel signal cardiovascular risk that warrants treatment beyond managing the ED itself. Men with ED should have a cardiovascular risk assessment as part of their investigation.
This page is for general information only and does not replace personalised medical advice. If you are worried about your health, please speak to a qualified healthcare professional. Trupoint Health blood tests are analysed by UK-accredited laboratories.
Private blood tests analysed by UK-accredited laboratories, with clear results and optional GP review.